Arkolith/Insider Trading/KLRA/Form 4

Jiangsu Hengrui Pharmaceuticals Co., Ltd.

10% OwnerKailera Therapeutics, Inc. (KLRA) · full profile →Form 4 · filed Apr 22, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
4
2 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 20, 2026Conversion(C)9.5M——9.5M
Apr 20, 2026Conversion(C)2.0M——2.0M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Apr 20, 2026Conversion(C)5.0M—$00
Apr 20, 2026Conversion(C)709K—$00

Transaction Codes

C
Conversion of a derivative

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-26-046276) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML